366 related articles for article (PubMed ID: 23632891)
21. Targeting BCL10 by small peptides for the treatment of B cell lymphoma.
Bao W; Sun C; Sun X; He M; Yu H; Yan W; Wen F; Zhang L; Yang C
Theranostics; 2020; 10(25):11622-11636. PubMed ID: 33052237
[No Abstract] [Full Text] [Related]
22. Role of the CARMA1/BCL10/MALT1 complex in lymphoid malignancies.
Juilland M; Thome M
Curr Opin Hematol; 2016 Jul; 23(4):402-9. PubMed ID: 27135977
[TBL] [Abstract][Full Text] [Related]
23. A Novel TRAF6 binding site in MALT1 defines distinct mechanisms of NF-kappaB activation by API2middle dotMALT1 fusions.
Noels H; van Loo G; Hagens S; Broeckx V; Beyaert R; Marynen P; Baens M
J Biol Chem; 2007 Apr; 282(14):10180-9. PubMed ID: 17287209
[TBL] [Abstract][Full Text] [Related]
24. Assembly mechanism of the CARMA1-BCL10-MALT1-TRAF6 signalosome.
David L; Li Y; Ma J; Garner E; Zhang X; Wu H
Proc Natl Acad Sci U S A; 2018 Feb; 115(7):1499-1504. PubMed ID: 29382759
[TBL] [Abstract][Full Text] [Related]
25. Inhibiting CARD11 translation during BCR activation by targeting the eIF4A RNA helicase.
Steinhardt JJ; Peroutka RJ; Mazan-Mamczarz K; Chen Q; Houng S; Robles C; Barth RN; DuBose J; Bruns B; Tesoriero R; Stein D; Fang R; Hanna N; Pasley J; Rodriguez C; Kligman MD; Bradley M; Rabin J; Shackelford S; Dai B; Landon AL; Scalea T; Livak F; Gartenhaus RB
Blood; 2014 Dec; 124(25):3758-67. PubMed ID: 25320244
[TBL] [Abstract][Full Text] [Related]
26. Characteristics of CARMA1-BCL10-MALT1-A20-NF-κB expression in T cell-acute lymphocytic leukemia.
Ma Y; Liao Z; Xu Y; Zhong Z; Wang X; Zhang F; Chen S; Yang L; Luo G; Huang X; Huang S; Wu X; Li Y
Eur J Med Res; 2014 Nov; 19(1):62. PubMed ID: 25384343
[TBL] [Abstract][Full Text] [Related]
27. Molecular pathways: targeting MALT1 paracaspase activity in lymphoma.
Fontán L; Melnick A
Clin Cancer Res; 2013 Dec; 19(24):6662-8. PubMed ID: 24004675
[TBL] [Abstract][Full Text] [Related]
28. The IRAK-1-BCL10-MALT1-TRAF6-TAK1 cascade mediates signaling to NF-kappaB from Toll-like receptor 4.
Dong W; Liu Y; Peng J; Chen L; Zou T; Xiao H; Liu Z; Li W; Bu Y; Qi Y
J Biol Chem; 2006 Sep; 281(36):26029-40. PubMed ID: 16831874
[TBL] [Abstract][Full Text] [Related]
29. MALT1/paracaspase is a signaling component downstream of CARMA1 and mediates T cell receptor-induced NF-kappaB activation.
Che T; You Y; Wang D; Tanner MJ; Dixit VM; Lin X
J Biol Chem; 2004 Apr; 279(16):15870-6. PubMed ID: 14754896
[TBL] [Abstract][Full Text] [Related]
30. IkappaB kinase beta-induced phosphorylation of CARMA1 contributes to CARMA1 Bcl10 MALT1 complex formation in B cells.
Shinohara H; Maeda S; Watarai H; Kurosaki T
J Exp Med; 2007 Dec; 204(13):3285-93. PubMed ID: 18086859
[TBL] [Abstract][Full Text] [Related]
31. COP9 signalosome controls the Carma1-Bcl10-Malt1 complex upon T-cell stimulation.
Welteke V; Eitelhuber A; Düwel M; Schweitzer K; Naumann M; Krappmann D
EMBO Rep; 2009 Jun; 10(6):642-8. PubMed ID: 19444310
[TBL] [Abstract][Full Text] [Related]
32. Intramolecular Interactions and Regulation of Cofactor Binding by the Four Repressive Elements in the Caspase Recruitment Domain-containing Protein 11 (CARD11) Inhibitory Domain.
Jattani RP; Tritapoe JM; Pomerantz JL
J Biol Chem; 2016 Apr; 291(16):8338-48. PubMed ID: 26884334
[TBL] [Abstract][Full Text] [Related]
33. Thrombin-dependent NF-{kappa}B activation and monocyte/endothelial adhesion are mediated by the CARMA3·Bcl10·MALT1 signalosome.
Delekta PC; Apel IJ; Gu S; Siu K; Hattori Y; McAllister-Lucas LM; Lucas PC
J Biol Chem; 2010 Dec; 285(53):41432-42. PubMed ID: 21041303
[TBL] [Abstract][Full Text] [Related]
34. MALT1 Phosphorylation Controls Activation of T Lymphocytes and Survival of ABC-DLBCL Tumor Cells.
Gehring T; Erdmann T; Rahm M; Graß C; Flatley A; O'Neill TJ; Woods S; Meininger I; Karayel O; Kutzner K; Grau M; Shinohara H; Lammens K; Feederle R; Hauck SM; Lenz G; Krappmann D
Cell Rep; 2019 Oct; 29(4):873-888.e10. PubMed ID: 31644910
[TBL] [Abstract][Full Text] [Related]
35. Ca2+/calmodulin-dependent protein kinase II is a modulator of CARMA1-mediated NF-kappaB activation.
Ishiguro K; Green T; Rapley J; Wachtel H; Giallourakis C; Landry A; Cao Z; Lu N; Takafumi A; Goto H; Daly MJ; Xavier RJ
Mol Cell Biol; 2006 Jul; 26(14):5497-508. PubMed ID: 16809782
[TBL] [Abstract][Full Text] [Related]
36. Multiple ITAM-coupled NK-cell receptors engage the Bcl10/Malt1 complex via Carma1 for NF-kappaB and MAPK activation to selectively control cytokine production.
Gross O; Grupp C; Steinberg C; Zimmermann S; Strasser D; Hannesschläger N; Reindl W; Jonsson H; Huo H; Littman DR; Peschel C; Yokoyama WM; Krug A; Ruland J
Blood; 2008 Sep; 112(6):2421-8. PubMed ID: 18192506
[TBL] [Abstract][Full Text] [Related]
37. Dephosphorylation of Carma1 by PP2A negatively regulates T-cell activation.
Eitelhuber AC; Warth S; Schimmack G; Düwel M; Hadian K; Demski K; Beisker W; Shinohara H; Kurosaki T; Heissmeyer V; Krappmann D
EMBO J; 2011 Feb; 30(3):594-605. PubMed ID: 21157432
[TBL] [Abstract][Full Text] [Related]
38. CD3/CD28 costimulation-induced NF-kappaB activation is mediated by recruitment of protein kinase C-theta, Bcl10, and IkappaB kinase beta to the immunological synapse through CARMA1.
Wang D; Matsumoto R; You Y; Che T; Lin XY; Gaffen SL; Lin X
Mol Cell Biol; 2004 Jan; 24(1):164-71. PubMed ID: 14673152
[TBL] [Abstract][Full Text] [Related]
39. Interplay between BCL10, MALT1 and IkappaBalpha during T-cell-receptor-mediated NFkappaB activation.
Carvalho G; Le Guelte A; Demian C; Vazquez A; Gavard J; Bidère N
J Cell Sci; 2010 Jul; 123(Pt 14):2375-80. PubMed ID: 20551178
[TBL] [Abstract][Full Text] [Related]
40. Kinase-independent feedback of the TAK1/TAB1 complex on BCL10 turnover and NF-κB activation.
Moreno-García ME; Sommer K; Rincon-Arano H; Brault M; Ninomiya-Tsuji J; Matesic LE; Rawlings DJ
Mol Cell Biol; 2013 Mar; 33(6):1149-63. PubMed ID: 23297344
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]